Cargando…

Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study

BACKGROUND: Oral anticoagulants are commonly used high-risk medications, but little is known about their safety in transition from hospital to home. Our objective was to measure the rates of hemorrhage and thromboembolic events among older adults receiving oral anticoagulant treatment early after ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Holbrook, Anne, Benipal, Harsukh, Paterson, J. Michael, Martins, Diana, Greaves, Simon, Lee, Munil, Gomes, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Joule Inc. or its licensors 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084547/
https://www.ncbi.nlm.nih.gov/pubmed/33863794
http://dx.doi.org/10.9778/cmajo.20200138
_version_ 1783686175989432320
author Holbrook, Anne
Benipal, Harsukh
Paterson, J. Michael
Martins, Diana
Greaves, Simon
Lee, Munil
Gomes, Tara
author_facet Holbrook, Anne
Benipal, Harsukh
Paterson, J. Michael
Martins, Diana
Greaves, Simon
Lee, Munil
Gomes, Tara
author_sort Holbrook, Anne
collection PubMed
description BACKGROUND: Oral anticoagulants are commonly used high-risk medications, but little is known about their safety in transition from hospital to home. Our objective was to measure the rates of hemorrhage and thromboembolic events among older adults receiving oral anticoagulant treatment early after hospital discharge compared to later. METHODS: We conducted a retrospective population-based cohort study among Ontario residents aged 66 years or more who started, continued or resumed oral anticoagulant therapy at hospital discharge between September 2010 and March 2015. We calculated the rates of hemorrhage and thromboembolic events requiring hospital admission or an emergency department visit over a 1-year follow-up period, stratified by the first 30 days after discharge and the remainder of the year. We used multivariable regression models, adjusting for covariates, to estimate the effect of sex, prevalent versus incident use, and switching anticoagulants on events. RESULTS: A total of 123 139 patients (68 408 women [55.6%]; mean age 78.2 yr) were included. About one-quarter (32 563 [26.4%]) had a Charlson Comorbidity Index score of 2 or higher. The rates of hemorrhage and thromboembolic events per 100 person-years were highest during the first 30 days after hospital discharge (25.8, 95% CI 24.8–26.8 and 19.3, 95% CI 18.4–20.2, respectively), falling to 15.7 (95% CI 15.3–16.1) and 6.9 (95% CI 6.6–7.1), respectively, during the subsequent 11 months. Multivariable analysis showed that patients whose anticoagulant was switched in hospital and men had more hemorrhages and thromboembolic events in follow-up. INTERPRETATION: The first few weeks following hospital discharge represent a very high-risk period for adverse events related to oral anticoagulant treatment among older adults. The results support an intervention trial addressing anticoagulation management in the early postdischarge period.
format Online
Article
Text
id pubmed-8084547
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Joule Inc. or its licensors
record_format MEDLINE/PubMed
spelling pubmed-80845472021-04-30 Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study Holbrook, Anne Benipal, Harsukh Paterson, J. Michael Martins, Diana Greaves, Simon Lee, Munil Gomes, Tara CMAJ Open Research BACKGROUND: Oral anticoagulants are commonly used high-risk medications, but little is known about their safety in transition from hospital to home. Our objective was to measure the rates of hemorrhage and thromboembolic events among older adults receiving oral anticoagulant treatment early after hospital discharge compared to later. METHODS: We conducted a retrospective population-based cohort study among Ontario residents aged 66 years or more who started, continued or resumed oral anticoagulant therapy at hospital discharge between September 2010 and March 2015. We calculated the rates of hemorrhage and thromboembolic events requiring hospital admission or an emergency department visit over a 1-year follow-up period, stratified by the first 30 days after discharge and the remainder of the year. We used multivariable regression models, adjusting for covariates, to estimate the effect of sex, prevalent versus incident use, and switching anticoagulants on events. RESULTS: A total of 123 139 patients (68 408 women [55.6%]; mean age 78.2 yr) were included. About one-quarter (32 563 [26.4%]) had a Charlson Comorbidity Index score of 2 or higher. The rates of hemorrhage and thromboembolic events per 100 person-years were highest during the first 30 days after hospital discharge (25.8, 95% CI 24.8–26.8 and 19.3, 95% CI 18.4–20.2, respectively), falling to 15.7 (95% CI 15.3–16.1) and 6.9 (95% CI 6.6–7.1), respectively, during the subsequent 11 months. Multivariable analysis showed that patients whose anticoagulant was switched in hospital and men had more hemorrhages and thromboembolic events in follow-up. INTERPRETATION: The first few weeks following hospital discharge represent a very high-risk period for adverse events related to oral anticoagulant treatment among older adults. The results support an intervention trial addressing anticoagulation management in the early postdischarge period. Joule Inc. or its licensors 2021-04-16 /pmc/articles/PMC8084547/ /pubmed/33863794 http://dx.doi.org/10.9778/cmajo.20200138 Text en © 2021 Joule Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research
Holbrook, Anne
Benipal, Harsukh
Paterson, J. Michael
Martins, Diana
Greaves, Simon
Lee, Munil
Gomes, Tara
Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study
title Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study
title_full Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study
title_fullStr Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study
title_full_unstemmed Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study
title_short Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study
title_sort adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084547/
https://www.ncbi.nlm.nih.gov/pubmed/33863794
http://dx.doi.org/10.9778/cmajo.20200138
work_keys_str_mv AT holbrookanne adverseeventratesassociatedwithoralanticoagulanttreatmentearlyversuslaterafterhospitaldischargeinolderadultsaretrospectivepopulationbasedcohortstudy
AT benipalharsukh adverseeventratesassociatedwithoralanticoagulanttreatmentearlyversuslaterafterhospitaldischargeinolderadultsaretrospectivepopulationbasedcohortstudy
AT patersonjmichael adverseeventratesassociatedwithoralanticoagulanttreatmentearlyversuslaterafterhospitaldischargeinolderadultsaretrospectivepopulationbasedcohortstudy
AT martinsdiana adverseeventratesassociatedwithoralanticoagulanttreatmentearlyversuslaterafterhospitaldischargeinolderadultsaretrospectivepopulationbasedcohortstudy
AT greavessimon adverseeventratesassociatedwithoralanticoagulanttreatmentearlyversuslaterafterhospitaldischargeinolderadultsaretrospectivepopulationbasedcohortstudy
AT leemunil adverseeventratesassociatedwithoralanticoagulanttreatmentearlyversuslaterafterhospitaldischargeinolderadultsaretrospectivepopulationbasedcohortstudy
AT gomestara adverseeventratesassociatedwithoralanticoagulanttreatmentearlyversuslaterafterhospitaldischargeinolderadultsaretrospectivepopulationbasedcohortstudy